Apimeds Pharmaceuticals US, Inc
General ticker "APUS" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $21.1M (TTM average)
Apimeds Pharmaceuticals US, Inc follows the US Stock Market performance with the rate: 23.9%.
Estimated limits based on current volatility of 5.6%: low 1.72$, high 1.92$
Factors to consider:
- Total employees count: 12 as of 2024
Short-term APUS quotes
Long-term APUS plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $0.64MM | $0.75MM | $1.28MM |
| Operating Income | $-0.64MM | $-0.75MM | $-1.28MM |
| Non-Operating Income | $-0.03MM | $-0.03MM | $-0.11MM |
| Interest Expense | $0.03MM | $0.04MM | $0.12MM |
| R&D Expense | $0.37MM | $0.10MM | $0.00MM |
| Income(Loss) | $-0.67MM | $-0.78MM | $-1.39MM |
| Profit(Loss)* | $-0.67MM | $-0.78MM | $-1.39MM |
| Stockholders Equity | $-0.71MM | $0.03MM | $-1.36MM |
| Assets | $0.01MM | $0.42MM | $0.01MM |
| Operating Cash Flow | $-0.45MM | $-0.63MM | $-0.73MM |
| Financing Cash Flow | $0.28MM | $1.03MM | $0.33MM |
| Earnings Per Share** | $-0.06 | $-0.07 | $-0.12 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.